StocktoriaAllarity Therapeutics, Inc. ALLR
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $320,000 | $0 | — | — | — |
| Gross profit | — | — | — | -$2.3M | — |
| Operating income | -$12.6M | -$27.2M | -$17.1M | -$34.5M | -$26.6M |
| Net income | -$11.2M | -$24.5M | -$11.9M | -$16.1M | -$26.6M |
| Operating cash flow | -$14.8M | -$17.4M | -$12.7M | -$16.8M | -$14.9M |
| Free cash flow | -$14.8M | -$17.6M | -$12.7M | -$16.8M | — |
| Total assets | $18.3M | $22.6M | $11.9M | $14.5M | $49.6M |
| Total liabilities | $8.4M | $10.8M | $14.6M | $12.7M | $30.8M |
| Shareholders' equity | $9.8M | $11.8M | -$2.8M | -$113,000 | $18.2M |
| Ratios | |||||
| Operating margin | -3939.1% | — | — | — | — |
| Net margin | -3509.7% | — | — | — | — |
| FCF margin | -4633.8% | — | — | — | — |
| Return on assets | -61.5% | -108.2% | -100.3% | -110.4% | -53.7% |
| Return on equity | -114.3% | -207.6% | 432.6% | 14210.6% | -146.8% |
| Debt / equity | — | — | -0.98× | -23.40× | — |
| Current ratio | 2.13 | 2.06 | 0.14 | 0.44 | 1.03 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 228,084 | $248,612 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001860657 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.